Tags

Type your tag names separated by a space and hit enter

National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder.
Pediatrics. 2007 Feb; 119 Suppl 1:S99-106.Ped

Abstract

OBJECTIVE

In this study we identified child and family-level characteristics that were associated with medication treatment for attention-deficit/hyperactivity disorder using nationally representative survey data.

METHODS

National Survey of Children's Health data from 79264 youth 4 to 17 years of age were used. Data were weighted to adjust for the complex survey design of the National Survey of Children's Health. Gender-specific logistic regression models were generated to identify child and family-level characteristics that were collectively associated with current medication status among youth with a reported diagnosis of attention-deficit/hyperactivity disorder.

RESULTS

Nationally, 7.8% of youth aged 4 to 17 years had a reported attention-deficit/hyperactivity disorder diagnosis, and 4.3% had both a disorder diagnosis and were currently taking medication for the disorder. Current medication treatment among youth with attention-deficit/hyperactivity disorder was associated with white race, younger age, English spoken in the home, health care coverage, a health care contact within the last year, and reported psychological difficulties. Gender-specific logistic regression models revealed that, together, younger age, higher income, health care coverage, having psychological difficulties, and a health care contact in the past year were associated with medication use among boys with attention-deficit/hyperactivity disorder. Among girls with the disorder, younger age, psychological difficulties, fair-to-poor paternal mental health status, and a health care contact within the last year were collectively associated with current medication use. CONCLUSIONS. Regardless of gender, younger age, the presence of psychological difficulties, and a recent health care contact were significantly associated with medication treatment for attention-deficit/hyperactivity disorder. However, additional health care access and income variables among boys and paternal mental health status among girls represented gender-specific factors that were also associated with medication treatment for the disorder. Future studies should characterize how and when the burden associated with attention-deficit/hyperactivity disorder leads to treatment, support, or services for this prevalent and impairing neurobehavioral disorder.

Authors+Show Affiliations

National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, 1600 Clifton Rd, Mailstop E-88, Atlanta, GA 30333, USA. svisser@cdc.govNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

17272592

Citation

Visser, Susanna N., et al. "National Estimates and Factors Associated With Medication Treatment for Childhood Attention-deficit/hyperactivity Disorder." Pediatrics, vol. 119 Suppl 1, 2007, pp. S99-106.
Visser SN, Lesesne CA, Perou R. National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder. Pediatrics. 2007;119 Suppl 1:S99-106.
Visser, S. N., Lesesne, C. A., & Perou, R. (2007). National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder. Pediatrics, 119 Suppl 1, S99-106.
Visser SN, Lesesne CA, Perou R. National Estimates and Factors Associated With Medication Treatment for Childhood Attention-deficit/hyperactivity Disorder. Pediatrics. 2007;119 Suppl 1:S99-106. PubMed PMID: 17272592.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder. AU - Visser,Susanna N, AU - Lesesne,Catherine A, AU - Perou,Ruth, PY - 2007/2/3/pubmed PY - 2007/4/6/medline PY - 2007/2/3/entrez SP - S99 EP - 106 JF - Pediatrics JO - Pediatrics VL - 119 Suppl 1 N2 - OBJECTIVE: In this study we identified child and family-level characteristics that were associated with medication treatment for attention-deficit/hyperactivity disorder using nationally representative survey data. METHODS: National Survey of Children's Health data from 79264 youth 4 to 17 years of age were used. Data were weighted to adjust for the complex survey design of the National Survey of Children's Health. Gender-specific logistic regression models were generated to identify child and family-level characteristics that were collectively associated with current medication status among youth with a reported diagnosis of attention-deficit/hyperactivity disorder. RESULTS: Nationally, 7.8% of youth aged 4 to 17 years had a reported attention-deficit/hyperactivity disorder diagnosis, and 4.3% had both a disorder diagnosis and were currently taking medication for the disorder. Current medication treatment among youth with attention-deficit/hyperactivity disorder was associated with white race, younger age, English spoken in the home, health care coverage, a health care contact within the last year, and reported psychological difficulties. Gender-specific logistic regression models revealed that, together, younger age, higher income, health care coverage, having psychological difficulties, and a health care contact in the past year were associated with medication use among boys with attention-deficit/hyperactivity disorder. Among girls with the disorder, younger age, psychological difficulties, fair-to-poor paternal mental health status, and a health care contact within the last year were collectively associated with current medication use. CONCLUSIONS. Regardless of gender, younger age, the presence of psychological difficulties, and a recent health care contact were significantly associated with medication treatment for attention-deficit/hyperactivity disorder. However, additional health care access and income variables among boys and paternal mental health status among girls represented gender-specific factors that were also associated with medication treatment for the disorder. Future studies should characterize how and when the burden associated with attention-deficit/hyperactivity disorder leads to treatment, support, or services for this prevalent and impairing neurobehavioral disorder. SN - 1098-4275 UR - https://www.unboundmedicine.com/medline/citation/17272592/National_estimates_and_factors_associated_with_medication_treatment_for_childhood_attention_deficit/hyperactivity_disorder_ L2 - http://pediatrics.aappublications.org/cgi/pmidlookup?view=long&pmid=17272592 DB - PRIME DP - Unbound Medicine ER -